DREAMM12
A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants With Normal and Varying Degrees of Impaired Renal Function
Arms / Cohorts
Experimental Arm:Patients with Normal / Mild Impaired Renal Function
Accepting patients
Experimental Arm:Patients with Severe Renal Impairment
Accepting patients
Experimental Arm:Patients with End Stage Renal Disease, Not on Dialysis
Accepting patients
Experimental Arm:Patients with End Stage Renal Disease, On Dialysis
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.